Yutaka Natori

Years Active: 2021-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Eisaku Sasaki, Yutaka Natori, Emi Tokuda, Reiko Kimura-Tsuchiya, Junko Suga, Kenya Kanazawa, Tomoyuki Koguchi, Nobuyuki Kikuchi, Naoyuki Okabe, Shigeyuki Murono, Kazunoshin Tachibana, Shu Soeda, Michio Shimabukuro, Shigehira Saji
Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event. Immunotherapy (2024)
Yutaka Natori, Junko Suga, Emi Tokuda, Kazunoshin Tachibana, Jun-Ichi Imai, Reiko Honma, Yusuke Azami, Masaru Noda, Eisaku Sasaki, Shinya Watanabe, Tohru Ohtake, Shigehira Saji
E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer. Cancers 15 (2) (2023)
Yutaka Natori, Junko Suga, Emi Tokuda, Kazunoshin Tachibana, Jun-Ichi Imai, Reiko Honma, Yusuke Azami, Masaru Noda, Eisaku Sasaki, Shinya Watanabe, Tohru Ohtake, Shigehira Saji
E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer. Cancers 15 (2) (2023)
Yutaka Natori, Eisaku Sasaki, Shu Soeda, Shigenori Furukawa, Yusuke Azami, Emi Tokuda, Takashi Kanbayashi, Shigehira Saji
Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab. Journal for immunotherapy of cancer 8 (2) (2021)

Yutaka Natori.css-eqlu8i{font-size:small;padding-left:4px;}